The neurotrophic hepatocyte growth factor induces protolerogenic human dendritic cells

Journal of Neuroimmunology

Volumn 267, Issue 1-2, 2014, Pages 105-110

  Molnarfi, Nicolas ^a,b   Benkhoucha, Mahdia ^a,b   Juillard, Catherine ^a   Bjarnadóttir, Kristbjörg ^a,b   Lalive, Patrice H ^a,b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Hepatocyte growth factor; Immune regulation; Monocyte derived dendritic cells; Multiple sclerosis (MS); Neuroinflammation

Indexed keywords

HLA DR ANTIGEN; SCATTER FACTOR;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG EFFECT; DRUG POTENTIATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MALE; MOLECULAR DYNAMICS; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; YOUNG ADULT;

HEPATOCYTE GROWTH FACTOR; IMMUNE REGULATION; MONOCYTE-DERIVED DENDRITIC CELLS; MULTIPLE SCLEROSIS (MS); NEUROINFLAMMATION;

ADULT; AGED; ANTIGENS, CD274; CYTOKINES; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; HEPATOCYTE GROWTH FACTOR; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; MONOCYTES; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84893694450     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2013.12.004     Document Type: Article

References (27)

1. Bai L., Lennon D.P., Caplan A.I., DeChant A., Hecker J., Kranso J., et al. Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models. Nat. Neurosci. 2012, 15:862-879.
2. Bartosik-Psujek H., Tabarkiewicz J., Pocinska K., Stelmasiak Z., Rolinski J. Immunomodulatory effects of vitamin D on monocyte-derived dendritic cells in multiple sclerosis. Mult. Scler. 2010, 16:1513-1516.
3. Benkhoucha M., Santiago-Raber M.L., Schneiter G., Chofflon M., Funakoshi H., Nakamura T., et al. Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:6424-6429.
4. Cella M., Dohring C., Samaridis J., Dessing M., Brockhaus M., Lanzavecchia A., et al. A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J. Exp. Med. 1997, 185:1743-1751.
5. Comabella M., Montalban X., Munz C., Lunemann J.D. Targeting dendritic cells to treat multiple sclerosis. Nat. Rev. Neurol. 2010, 6:499-507.
6. Dhodapkar M.V., Steinman R.M., Krasovsky J., Munz C., Bhardwaj N. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 2001, 193:233-238.
7. Ebens A., Brose K., Leonardo E.D., Hanson M.G., Bladt F., Birchmeier C., et al. Hepatocyte growth factor/scatter factor is an axonal chemoattractant and a neurotrophic factor for spinal motor neurons. Neuron 1996, 17:1157-1172.
8. Hemmer B., Hartung H.P. Toward the development of rational therapies in multiple sclerosis: what is on the horizon?. Ann. Neurol. 2007, 62:314-326.
9. Herbst B., Kohler G., Mackensen A., Veelken H., Mertelsmann R., Lindemann A. CD34+ peripheral blood progenitor cell and monocyte derived dendritic cells: a comparative analysis. Br. J. Haematol. 1997, 99:490-499.
10. Huang Y.M., Stoyanova N., Jin Y.P., Teleshova N., Hussien Y., Xiao B.G., et al. Altered phenotype and function of blood dendritic cells in multiple sclerosis are modulated by IFN-beta and IL-10. Clin. Exp. Immunol. 2001, 124:306-314.
11. Huang Y.M., Xiao B.G., Ozenci V., Kouwenhoven M., Teleshova N., Fredrikson S., et al. Multiple sclerosis is associated with high levels of circulating dendritic cells secreting pro-inflammatory cytokines. J. Neuroimmunol. 1999, 99:82-90.
12. Karni A., Abraham M., Monsonego A., Cai G., Freeman G.J., Hafler D., et al. Innate immunity in multiple sclerosis: myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response. J. Immunol. 2006, 177:4196-4202.
13. Kitamura K., Iwanami A., Nakamura M., Yamane J., Watanabe K., Suzuki Y., et al. Hepatocyte growth factor promotes endogenous repair and functional recovery after spinal cord injury. J. Neurosci. Res. 2007, 85:2332-2342.
14. Lalive P.H., Paglinawan R., Biollaz G., Kappos E.A., Leone D.P., Malipiero U., et al. TGF-beta-treated microglia induce oligodendrocyte precursor cell chemotaxis through the HGF-c-Met pathway. Eur. J. Immunol. 2005, 35:727-737.
15. Molnarfi N., Benkhoucha M., Bjarnadottir K., Juillard C., Lalive P.H. Interferon-beta induces hepatocyte growth factor in monocytes of multiple sclerosis patients. PLoS One 2012, 7:e49882.
16. Muller A.M., Jun E., Conlon H., Sadiq S.A. Cerebrospinal hepatocyte growth factor levels correlate negatively with disease activity in multiple sclerosis. J. Neuroimmunol. 2012, 251(1-2):80-86.
17. Nakamura T., Sakai K., Nakamura T., Matsumoto K. Hepatocyte growth factor twenty years on: much more than a growth factor. J. Gastroenterol. Hepatol. 2011, 26(Suppl. 1):188-202.
18. Nuyts A., Lee W., Bashir-Dar R., Berneman Z., Cools N. Dendritic cells in multiple sclerosis: key players in the immunopathogenesis, key players for new cellular immunotherapies?. Mult. Scler. 2013, 19:995-1002.
19. Raiotach-Regue D., Grau-Lopez L., Naranjo-Gomez M., Ramo-Tello C., Pujol-Borrell R., Martinez-Caceres E., et al. Stable antigen-specific T-cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patients. Eur. J. Immunol. 2012, 42:771-782.
20. Rutella S., Bonanno G., Procoli A., Mariotti A., de Ritis D.G., Curti A., et al. Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features. Blood 2006, 108:218-227.
21. Sospedra M., Martin R. Immunology of multiple sclerosis. Annu. Rev. Immunol. 2005, 23:683-747.
22. Steinman R.M., Banchereau J. Taking dendritic cells into medicine. Nature 2007, 449:419-426.
23. Tsuboi Y., Kakimoto K., Akatsu H., Daikuhara Y., Yamada T. Hepatocyte growth factor in cerebrospinal fluid in neurologic disease. Acta Neurol. Scand. 2002, 106:99-103.
24. Vaknin-Dembinsky A., Balashov K., Weiner H.L. IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production. J. Immunol. 2006, 176:7768-7774.
25. Vaknin-Dembinsky A., Murugaiyan G., Hafler D.A., Astier A.L., Weiner H.L. Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis. J. Neuroimmunol. 2008, 195:140-145.
26. Wang L., Pino-Lagos K., de Vries V.C., Guleria I., Sayegh M.H., Noelle R.J. Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:9331-9336.
27. Zhou L.J., Tedder T.F. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:2588-2592.